6,390 Shares in Ventas, Inc. $VTR Acquired by FJ Capital Management LLC

FJ Capital Management LLC acquired a new position in shares of Ventas, Inc. (NYSE:VTRFree Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 6,390 shares of the real estate investment trust’s stock, valued at approximately $494,000.

Several other institutional investors have also recently modified their holdings of VTR. Vanguard Group Inc. grew its stake in shares of Ventas by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock valued at $5,876,856,000 after buying an additional 2,349,176 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Ventas by 1.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock valued at $2,078,794,000 after acquiring an additional 387,495 shares in the last quarter. State Street Corp lifted its holdings in Ventas by 2.5% in the 4th quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after buying an additional 735,620 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Ventas by 3.8% in the 4th quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after buying an additional 475,633 shares in the last quarter. Finally, Capital World Investors acquired a new position in Ventas in the 4th quarter worth $594,116,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.53% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company upped their target price on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. BMO Capital Markets restated an “outperform” rating and issued a $100.00 target price on shares of Ventas in a research note on Monday, May 4th. Jefferies Financial Group upped their target price on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Mizuho set a $98.00 price objective on shares of Ventas in a research note on Friday, May 22nd. Finally, Royal Bank Of Canada increased their price objective on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Ventas currently has an average rating of “Moderate Buy” and an average price target of $95.19.

Read Our Latest Analysis on Ventas

Ventas Trading Up 0.8%

Shares of NYSE:VTR opened at $84.58 on Friday. The stock has a market capitalization of $41.12 billion, a price-to-earnings ratio of 153.79, a PEG ratio of 1.82 and a beta of 0.71. Ventas, Inc. has a 1-year low of $61.76 and a 1-year high of $91.06. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The company has a 50 day moving average price of $85.15 and a 200 day moving average price of $82.48.

Ventas (NYSE:VTRGet Free Report) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company’s quarterly revenue was up 22.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, research analysts anticipate that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.52 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s dividend payout ratio (DPR) is currently 378.18%.

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

See Also

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.